323 related articles for article (PubMed ID: 21631635)
21. Lentigo maligna and radiotherapy.
Wilson LD
N Engl J Med; 2006 Mar; 354(12):1322; author reply 1322. PubMed ID: 16554541
[No Abstract] [Full Text] [Related]
22. Five-year recurrence rate of lentigo maligna after treatment with imiquimod.
Kai AC; Richards T; Coleman A; Mallipeddi R; Barlow R; Craythorne EE
Br J Dermatol; 2016 Jan; 174(1):165-8. PubMed ID: 26595446
[TBL] [Abstract][Full Text] [Related]
23. Amelanotic lentigo maligna managed with topical imiquimod as immunotherapy.
Powell AM; Russell-Jones R
J Am Acad Dermatol; 2004 May; 50(5):792-6. PubMed ID: 15097969
[TBL] [Abstract][Full Text] [Related]
24. A systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures.
Tio D; van der Woude J; Prinsen CAC; Jansma EP; Hoekzema R; van Montfrans C
J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):616-624. PubMed ID: 27987308
[TBL] [Abstract][Full Text] [Related]
25. Imiquimod in the treatment of lentigo maligna.
Rajpar SF; Marsden JR
Br J Dermatol; 2006 Oct; 155(4):653-6. PubMed ID: 16965411
[TBL] [Abstract][Full Text] [Related]
26. Topical imiquimod therapy for lentigo maligna.
Mahoney MH; Joseph MG; Temple C
Ann Plast Surg; 2008 Oct; 61(4):419-24. PubMed ID: 18812714
[TBL] [Abstract][Full Text] [Related]
27. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma using Mel-5 immunostaining: University of Minnesota experience.
Bhardwaj SS; Tope WD; Lee PK
Dermatol Surg; 2006 May; 32(5):690-6; discussion 696-7. PubMed ID: 16706765
[TBL] [Abstract][Full Text] [Related]
28. [Lentigo maligna treated with 5% imiquimod cream].
Martín T; Ojeda A; Martínez S; Vera A
Actas Dermosifiliogr; 2005 Dec; 96(10):700-2. PubMed ID: 16476324
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of imiquimod cream, 5%, for lentigo maligna after complete excision: a study of 43 patients.
Ly L; Kelly JW; O'Keefe R; Sutton T; Dowling JP; Swain S; Byrne M; Curr N; Wolfe R; Chamberlain A; Haskett M
Arch Dermatol; 2011 Oct; 147(10):1191-5. PubMed ID: 22006136
[TBL] [Abstract][Full Text] [Related]
30. A systematic review of non-surgical treatments for lentigo maligna.
Read T; Noonan C; David M; Wagels M; Foote M; Schaider H; Soyer HP; Smithers BM
J Eur Acad Dermatol Venereol; 2016 May; 30(5):748-53. PubMed ID: 26299846
[TBL] [Abstract][Full Text] [Related]
31. A novel two-stage treatment of lentigo maligna using ablative laser therapy followed by imiquimod.
de Vries K; Rellum R; Habets JM; Prens EP
Br J Dermatol; 2013 Jun; 168(6):1362-4. PubMed ID: 23252724
[No Abstract] [Full Text] [Related]
32. Surgical and histologic pitfalls in the management of lentigo maligna melanoma.
Situm M; Buljan M
G Ital Dermatol Venereol; 2012 Feb; 147(1):21-7. PubMed ID: 22370566
[TBL] [Abstract][Full Text] [Related]
33. Lentigo maligna: one size does not fit all.
Bowen GM; Bowen AR; Florell SR
Arch Dermatol; 2011 Oct; 147(10):1211-3. PubMed ID: 22006139
[No Abstract] [Full Text] [Related]
34. Successful treatment of lentigo maligna and lentigo maligna melanoma with Mohs' micrographic surgery aided by rush permanent sections.
Cohen LM; McCall MW; Hodge SJ; Freedman JD; Callen JP; Zax RH
Cancer; 1994 Jun; 73(12):2964-70. PubMed ID: 8199993
[TBL] [Abstract][Full Text] [Related]
35. Real-world experience of off-label use of imiquimod 5% as an adjuvant therapy after surgery or as a monotherapy for lentigo maligna.
Lallas A; Moscarella E; Kittler H; Longo C; Thomas L; Zalaudek I; Kyrgidis A; Manoli SM; di Meo N; Papageorgiou C; Apalla Z; Argenziano G
Br J Dermatol; 2021 Sep; 185(3):675-677. PubMed ID: 33894006
[No Abstract] [Full Text] [Related]
36. Staged margin control techniques for surgical excision of lentigo maligna.
Raziano RM; Clark GS; Cherpelis BS; Sondak VK; Cruse CW; Fenske NA; Glass LF
G Ital Dermatol Venereol; 2009 Jun; 144(3):259-70. PubMed ID: 19528907
[TBL] [Abstract][Full Text] [Related]
37. Geometric staged excision for the treatment of lentigo maligna and lentigo maligna melanoma: a long-term experience with literature review.
Abdelmalek M; Loosemore MP; Hurt MA; Hruza G
Arch Dermatol; 2012 May; 148(5):599-604. PubMed ID: 22782151
[TBL] [Abstract][Full Text] [Related]
38. Clinical and histologic features associated with lentigo maligna clearance after imiquimod treatment.
Kwak R; Joyce C; Werchniak AE; Lin JY; Tsibris HC
J Dermatolog Treat; 2022 Jun; 33(4):1995-1999. PubMed ID: 34315342
[TBL] [Abstract][Full Text] [Related]
39. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma. A follow-up study.
Cohen LM; McCall MW; Zax RH
Dermatol Surg; 1998 Jun; 24(6):673-7. PubMed ID: 9648576
[TBL] [Abstract][Full Text] [Related]
40. Rate of recurrence following treatment of lentigo maligna with carbon dioxide laser alone or in combination with imiquimod: Results of a long-term study.
Kaur A; Javed MU; Venables B; Murison M; Yarrow J
J Plast Reconstr Aesthet Surg; 2023 Oct; 85():95-97. PubMed ID: 37473646
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
